Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations.

Banzhoff, Angelika; Haertel, Sabine; Praus, Michaela

Banzhoff, Angelika; Haertel, Sabine; Praus, Michaela.

Affiliation

Banzhoff A; Novartis Vaccines and Diagnostics, Marburg, Germany. angelika.banzhoff@novartis.com

Hum Vaccin ; 7(5): 539-48, 2011 May.

Article in En | MEDLINE | ID: mdl-21422814

Subject(s)

Adjuvants, Immunologic/adverse effects; Influenza A Virus, H1N1 Subtype/immunology; Influenza Vaccines/adverse effects; Influenza, Human/prevention & control; Mass Vaccination/adverse effects; Pandemics; Polysorbates/adverse effects; Squalene/adverse effects; Adjuvants, Immunologic/administration & dosage; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Europe/epidemiology; Female; Humans; Incidence; Infant; Infant, Newborn; Influenza Vaccines/administration & dosage; Influenza, Human/epidemiology; Male; Middle Aged; Polysorbates/administration & dosage; Squalene/administration & dosage; Survival Analysis; Young Adult

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polysorbates / Squalene / Influenza Vaccines / Adjuvants, Immunologic / Mass Vaccination / Influenza, Human / Influenza A Virus, H1N1 Subtype / Pandemics Type of study: Incidence_studies / Prognostic_studies / Screening_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: Hum Vaccin Journal subject: ALERGIA E IMUNOLOGIA Year: 2011 Type: Article Affiliation country: Germany

Search on Google

XML

PubMed Links